Karbon-X Project Inc.
9.2.2024 23:18:17 CET | ACCESS Newswire | Press release
CALGARY, AB and MONROVIA, LIBERIA / ACCESSWIRE / February 9, 2024 / In a groundbreaking move for environmental sustainability and economic revitalization, Karbon-X Project Inc. (OTC PINK:KARX), a leader in carbon offset solutions, has partnered with Revive Terra Corps, a pioneer in ecosystem restoration and sustainable agriculture, to initiate a biochar manufacturing project at a former rubber plantation in Liberia. This collaboration marks a significant step towards combating climate change, enhancing biodiversity, and fostering economic growth in one of Africa's most resource-rich yet underutilized regions.
Under the agreement, Karbon-X will lend its expertise in project design, implementation, and the marketing of voluntary carbon offsets. In exchange, Karbon-X will receive a 50% share of all future biochar offsets generated, symbolizing a shared commitment to environmental restoration and sustainable development. The partnership encapsulates a comprehensive plan including the supply of state-of-the-art Vario L+ biochar units, on-site commissioning, training, and the provision of essential services to ensure the project's success.
This project represents a holistic approach to revitalizing abandoned rubber tree plantations, thereby addressing critical issues such as economic stability, food security, and environmental restoration in Liberia. "Our deal with Revive Terra will bring economic and ecological revitalization to an area of the world that's been neglected in recent years, Karbon-X is extremely proud to be a part of it." said Chad Clovis, CEO of Karbon-X.
Liberia, with its vast equatorial rainforests and fertile agricultural lands, presents an ideal setting for this initiative. The rubber plantation, spanning 245,000 hectares along the Sinoe River, offers a unique combination of secondary forest and previously cultivated land, now poised for transformation into a biochar production hub. This venture promises to leverage local resources and labor, contributing significantly to the region's economic development and sustainability goals.
The project is poised to deliver substantial social assistance, including healthcare, retirement benefits, and support for local infrastructure such as hospitals and schools, in a region that has faced nearly 100% unemployment since the Liberian civil war. By tapping into the growing market for sustainable wood products and energy generation, Revive Terra is set to generate increased returns for shareholders while fostering environmental stewardship and community empowerment.
Karbon-X brings a wealth of experience and innovation to the partnership, ensuring the project's success and sustainability. With a history of partnering with industries across the spectrum to meet ESG goals, Karbon-X stands ready to democratize access to carbon credits, enhancing the project's global reach and impact.
This partnership between Karbon-X Project Inc and Revive Terra Corps represents a visionary approach to restoring natural habitats, combating climate change, and revitalizing local economies through innovation and sustainable practices. It signals a hopeful future for Liberia and a model for sustainable development worldwide.
About Karbon-X Project Inc
Karbon-X Project Inc. specializes in providing internationally verified carbon credits, meeting companies' ESG goals through innovative solutions. With a strong focus on quality and efficiency, Karbon-X is at the forefront of the carbon offset market, offering seamless integration of carbon credit solutions for businesses and consumers alike.
Karbon-X provides access to carbon offsets for everyday people via an easy subscription service both through its website and its app via karbon-x.com.
About Revive Terra Corps
Revive Terra Corps is dedicated to restoring natural habitats, enhancing biodiversity, and combating climate change through sustainable agricultural systems. By empowering local communities with the knowledge, resources, and technologies needed for sustainable development, Revive Terra is creating lasting change in Africa's ecosystems and economies.
Contact Information
For media inquiries and more information on this partnership, please contact:
Head of Marketing at Karbon-X
Daniel Haigh
dh@karbon-x.com
1 587 577 3863
SOURCE: Karbon-X Project Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom